0

Independent Certified Satellite Symposium Treatment Advances with Novel Anti-Androgen Therapy, PARP Inhibitors, and NGI For Hormone-Sensitive and Castration-Resistant Prostate Cancer

Date
November 10, 2023
Explore related products in the following collection:

Click here to RSVP! Supported by educational grants from Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC.

Related Products

Thumbnail for New Drug Updates in Hematologic Malignancies
New Drug Updates in Hematologic Malignancies
Rebecca Rezac has no relevant financial relationships to disclose…
Thumbnail for Bringing Up Hospice Doesn't Have to be Uncomfortable: Clinical Pearls for Your Practice
Bringing Up Hospice Doesn't Have to be Uncomfortable: Clinical Pearls for Your Practice
Judy Knudson has no relevant financial relationships to disclose…
Thumbnail for Improving Prostate Cancer Patient Care in the Clinical Setting
Improving Prostate Cancer Patient Care in the Clinical Setting
Jessica Deinert has no relevant financial relationships to disclose…